(November 16-17, 2002)
The program is summarized below. We have been able to provide Powerpoint Presentations for selected talks. Refer to the links below.*
TFP is an effective psychodynamically-oriented psychotherapy, capable of producing dramatic clinical change in patients with personality disorders, including Borderline and Narcissistic. TFP decreases self-destructive behavior, improves affect regulation, and targets interpersonal difficulties that interfere with an individualís ability to function at work and in relationships. Improvement is a result of fundamental change in personality structure.
This symposium presents a state of the art understanding of BPD, specialized treatment approach, recent research findings and future research directions. This symposium is designed for clinicians in a variety of treatment settings private practice, clinic, and hospital interested in learning techniques to manage and treat the difficult patient. Participants should have clinical experience treating patients with personality disorders and an understanding of basic psychodynamic principles.
Participants will be able to:
Recommended reading prior to the conference.
|Day 1 — November 16, 2002 — General Introduction and Special Topics|
|8:30-8:45||Introductory remarks Otto Kernberg, MD|
|8:45-9:15*||Factors that Shape Borderline Personality Biological/Constitutional and Developmental Otto Kernberg, MD|
|9:15-10:00*||Summary of TFP:† Theory and Techniques Frank Yeomans, MD|
|10:00-10:30*||How TFP Addresses Depression and Suicidality, with Considerations of Differential Diagnosis Sonia Kulchycky, MD|
|10:45-11:15||How TFP Addresses Trauma and Dissociative Symptoms Ann Appelbaum, MD|
|11:15-12:00||Psychopharmacology of BPD Symptoms: Practice Guidelines Paul Soloff, MD|
|12:00-12:45||Thoughts on a Contemporary Psychodynamic Approach to Borderline Psychopathology and Treatment of Borderline Patients Peter Fonagy, PhD|
|AFTERNOON — OPTION I:|
|1:45-2:30||Narcissistic Resistances and Antisocial Behaviors Pamela Foelsch, PhD|
|2:30-3:15||Borderline Personality in Children and Adolescents Paulina Kernberg, MD|
|3:15-4:00||Impact of Attachment Status Diana Diamond, PhD|
|4:15-5:00||Erotic and Sadistic Transferences/Countertransferences Otto Kernberg, MD|
|AFTERNOON — OPTION II:|
|1:45-3:45||Comparing TFP, DBT and Supportive Therapies:† Clinical Management of Critical Moments in Treating Borderline Patients Otto Kernberg, MD, Barbara Stanley, PhD, Ann Appelbaum, MD, moderated by John Clarkin, PhD|
|4:00-5:00*||Supervision of TFP Frank Yeomans, MD, Pamela Foelsch, PhD|
|Day 2 — November 17, 2002 — Research and Advanced Training|
|8:30-10:15||Supervision using Videotapes of Sessions Otto Kernberg, MD and TFP Supervisors [This session is open only to members of TFP training sites]|
|10:30-11:30||Presentation of Personality Disorders Institute research Swiss Foundation and NIMH John Clarkin, PhD, Ken Levy, PhD, and David Silbersweig, MD 1 - Results to date, 2 - Ongoing projects, Discussant: Peter Fonagy, PhD|
|11:30-12:00||Future Directions of TFP Otto Kernberg, MD and Frank Yeomans, MD|
|12:15-12:45||Challenges of Research on BPD in Children and Adolescents Lina Normandin, PhD|
|12:45-1:15||Progress Report on Dutch Study Comparing TFP and CBT over Three Years of Therapy Josephine Geisen-Bloo, PhD with Leo Swaab, MSW, Kees Kooiman, MD, and Paul Wijts MD|
|1:15- 2:15||LUNCH BREAK|
|2:15-2:45*||Psychopathy Michael Stone, MD|
|2:45-3:15||Comparison of TFP vs. Supportive Therapy over 48 sessions David Lopez Garza, MD|
|3:15-4:00*||Organizing and Training Therapists in the Community Peter Buchheim, MD [Munich], Pamela Foelsch, PhD [New York], David Lopez Garza, MD [Mexico], Lina Normandin PhD [Quebec], Michael Stigler, MD [Switzerland], Leo Swaab, MSW [The Netherlands], Moderator: Frank Yeomans MD|
|4:15-5:00||The Transference-Countertransference Assessment Instrument Pamela Foelsch, PhD and Lina Normandin, PhD|
|5:00-5:45||Summary Dialogue John Clarkin, PhD, Peter Fonagy, PhD and Michael Stone, MD|
Weill Medical College of Cornell University designated this educational activity for a maximum of 12.5 credit hours in Category 1 credit towards AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
We are accredited for psychiatrists since we function in the context of a medical school. Our CME Office informs us that by attending this conference you will receive a CME certificate of attendance that you can present to your own accrediting agency. Other agencies typically grant continuing education credits if approved for CME's.
This Weill Cornell CME activity was funded in part by an unrestricted educational grant from Janssen Pharmaceuticals.
It is the policy of Weill Medical College of Cornell University to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose to the audience any potential, apparent, or real conflict of interest related to their contribution to the activity, and any discussions of unlabelled or uninvestigated use of any commercial product or device not yet approved in the United States.